Clofazimine (B663, Geigy) in leprosy reactions.

Suppr

超能文献

作者信息

Smith R B

出版信息

Australas J Dermatol. 1972 Apr;13(1):31-5. doi: 10.1111/j.1440-0960.1972.tb00480.x.

DOI:10.1111/j.1440-0960.1972.tb00480.x

PMID:5082494

Abstract

摘要

相似文献

Clofazimine (B663, Geigy) in leprosy reactions.

Australas J Dermatol. 1972 Apr;13(1):31-5. doi: 10.1111/j.1440-0960.1972.tb00480.x.

Efficacy of clofazimine in the prophylaxis and suppression of reactive phases of lepromatous leprosy.

Int J Lepr Other Mycobact Dis. 1971 Oct-Dec;39(4):838-41.

Chemotherapy of leprosy.

Int J Lepr Other Mycobact Dis. 1971 Apr-Jun;39(2):462-6.

Therapy of leprosy.

Bull World Health Organ. 1970;42(5):667-72.

Correlation of laboratory and clinical data during treatment of leprosy.

Ann Soc Belg Med Trop. 1972;52(6):537-48.

The treatment of leprosy and its acute complications.

Trop Doct. 1973 Jan;3(1):8-11. doi: 10.1177/004947557300300105.

Controlled drug trial of B.663 compared with DDS. Preliminary (48 week) report.

Int J Lepr Other Mycobact Dis. 1971 Jul-Sep;39(3):738-41.

Antibacterial effects of G 30'320 Geigy (B663) in lepromatous leprosy.

Dermatol Int. 1969 Jan-Mar;8(1):21-7. doi: 10.1111/j.1365-4362.1969.tb05324.x.

Clofazimine therapy of lepromatous leprosy caused by dapsone-resistant mycobacterium leprae.

Am J Trop Med Hyg. 1972 May;21(3):315-21. doi: 10.4269/ajtmh.1972.21.315.

[Lampren in the treatment of leprosy].

Schweiz Rundsch Med Prax. 1970 Mar 17;59(11):387-9.

引用本文的文献

Mining Natural Compounds to Target WNT Signaling: Land and Sea Tales.

Handb Exp Pharmacol. 2021;269:215-248. doi: 10.1007/164_2021_530.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Clofazimine (B663, Geigy) in leprosy reactions.

Australas J Dermatol. 1972 Apr;13(1):31-5. doi: 10.1111/j.1440-0960.1972.tb00480.x.

Efficacy of clofazimine in the prophylaxis and suppression of reactive phases of lepromatous leprosy.

Int J Lepr Other Mycobact Dis. 1971 Oct-Dec;39(4):838-41.

Chemotherapy of leprosy.

Int J Lepr Other Mycobact Dis. 1971 Apr-Jun;39(2):462-6.

Therapy of leprosy.

Bull World Health Organ. 1970;42(5):667-72.

Correlation of laboratory and clinical data during treatment of leprosy.

Ann Soc Belg Med Trop. 1972;52(6):537-48.

The treatment of leprosy and its acute complications.

Trop Doct. 1973 Jan;3(1):8-11. doi: 10.1177/004947557300300105.

Controlled drug trial of B.663 compared with DDS. Preliminary (48 week) report.

Int J Lepr Other Mycobact Dis. 1971 Jul-Sep;39(3):738-41.

Antibacterial effects of G 30'320 Geigy (B663) in lepromatous leprosy.

Dermatol Int. 1969 Jan-Mar;8(1):21-7. doi: 10.1111/j.1365-4362.1969.tb05324.x.

Clofazimine therapy of lepromatous leprosy caused by dapsone-resistant mycobacterium leprae.

Am J Trop Med Hyg. 1972 May;21(3):315-21. doi: 10.4269/ajtmh.1972.21.315.

[Lampren in the treatment of leprosy].

Schweiz Rundsch Med Prax. 1970 Mar 17;59(11):387-9.

引用本文的文献

Mining Natural Compounds to Target WNT Signaling: Land and Sea Tales.

Handb Exp Pharmacol. 2021;269:215-248. doi: 10.1007/164_2021_530.